Declaration

PetDx raises $62 million in Series B financing to scale adoption of its canine multi-cancer early detection blood test, OncoK9

https://declarationpartners.com/wp-content/uploads/2022/02/Screenshot-2022-02-16-at-19.39.36.png

Declaration is thrilled to help accelerate the adoption of PetDx’s non-invasive canine oncology test, which uses next generation sequencing for the early detection of many types of cancer in dogs with a simple blood draw. 

https://www.prnewswire.com/news-releases/petdx-raises-62-million-in-series-b-financing-to-scale-adoption-of-its-canine-multi-cancer-early-detection-blood-test-oncok9-301440845.html?utm_source